Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein aggregate myopathies.

Hans H Goebel1, Harald D Müller

  • 1Department of Neuropathology, Johannes Gutenberg University, Mainz, Germany. neuropatho.klinik.uni-mainz.de

Seminars in Pediatric Neurology
|October 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monoclonal Gammopathy - the common denominator of sporadic late-onset nemaline myopathy and paraproteinemic neuropathy.

Neuromuscular disorders : NMD·2026
Same author

The spectrum of the "Historical section".

Neuromuscular disorders : NMD·2025
Same author

Valosin-Containing Protein Multisystem Proteinopathy and Myopathology.

Neurology. Genetics·2025
Same author

3D Electron Microscopic Visualization of Nemaline Rods in a Case of Congenital Myopathy.

Neurology·2025
Same author

Meeting report of the 20th International Congress of Neuropathology (ICN) 2023 in Berlin.

Brain pathology (Zurich, Switzerland)·2024
Same author

"MUSCLE BIOPSY" - Its 50th anniversary to this year.

Neuromuscular disorders : NMD·2024
Same journal

Concussion in contact sport: risks, detection, & prevention.

Seminars in pediatric neurology·2026
Same journal

A multidisciplinary, symptom-targeted approach to rehabilitation in pediatric concussion.

Seminars in pediatric neurology·2026
Same journal

Pediatric concussion beyond sports: Falls, play, and everyday activities.

Seminars in pediatric neurology·2026
Same journal

Return-to-school protocols in pediatric concussion care.

Seminars in pediatric neurology·2026
Same journal

Improving concussion recognition in youth sports: the role of parents, coaches, and community education.

Seminars in pediatric neurology·2026
Same journal

Concussion management, rehabilitation, and societal impact.

Seminars in pediatric neurology·2026
See all related articles

Protein aggregate myopathies (PAMs) affect muscle fibers in children and adults, often linked to genetic mutations. Diagnosis requires muscle biopsy and advanced analysis, with no cure currently available.

Area of Science:

  • Neurology
  • Genetics
  • Pathology

Background:

  • Protein aggregate myopathies (PAMs) are characterized by abnormal protein aggregation within muscle fibers.
  • These myopathies can manifest in childhood (e.g., selenoproteinopathies, actinopathies, myosinopathies) or adulthood (e.g., myofibrillar myopathies).
  • PAMs can be mutation-related, particularly in childhood forms, or sporadic, predominantly in adults.

Purpose of the Study:

  • To classify and describe protein aggregate myopathies.
  • To outline diagnostic approaches for identifying specific PAM entities.
  • To highlight the current limitations in understanding pathogenesis and treatment.

Main Methods:

  • Classification based on identifying specific mutant proteins, often sarcomeric components.

Related Experiment Videos

  • Diagnosis involves muscle biopsy with extensive immunohistochemical and electron microscopic examination.
  • Subsequent molecular analysis of identified proteins is crucial for definitive diagnosis.

    • Main Results:

    • PAMs are categorized based on the affected proteins, including those in myofibrils, desmin, actin, and myosin.
    • Diagnostic workflow integrates morphological and molecular analyses for precise identification.
    • Genetic counseling is facilitated by accurate diagnosis of individual PAM entities.

    Conclusions:

    • Accurate diagnosis of PAMs relies on integrated morphological and molecular investigations.
    • Understanding the pathogenetic mechanisms of PAMs remains incomplete.
    • Currently, causative therapies for protein aggregate myopathies are unavailable.